Navigation Links
Iodex goes to SmithKline Beecham consumer Healthcare

Iodex is the market leader in the pain-balm segment, with a market share of 70 per cent-plus. Iodex faces challenges from local brands like Amrutanjan, Tiger Balm (locally manufactured by Elder Pharma), Zandu Balm and Sensur of Glenmark. //

Glaxo SmithKline India (GSK) has decided to transfer its Iodex range of products to SmithKline Beecham Consumer Healthcare (SKBCH), a GSK subsidiary. SKBCH has a strong marketing and distribution network in India, comprising over 1,600 wholesalers and direct coverage of over 4,00,000 retail outlets.

Last year, Glaxo India and SmithKline Beecham Pharmaceutical India had merged and it was announced that the focus of the merged entity, GSK, would give more focus on prescription drugs and vaccines rather than over-the-counter (OTC) products. The officials said with this transfer of the Iodex brand, the entire promotion, marketing and distribution will be carried out by SKBCH, a leading player in the OTC segment.

The Iodex brand was owned by SmithKline Beecham Plc, the British parent, and had been licensed to SmithKline Beecham Pharmaceuticals India. Iodex has a turnover of around Rs 100 crore, and analysts say it could be valued at Rs 300 crore. The pain-and-rub market in India is currently valued in the Rs 350-400 crore range.
'"/>




Page: 1

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. GlaxoSmithKline To Cultivate Non-Smoking Environment
3. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
4. FDA Mislead On Asthma Drug By GlaxoSmithKline
5. GlaxoSmithKline Defends Its Products
6. GlaxoSmithKline launches diabetes and cancer drugs
7. Generic Products Compete With GlaxoSmithKline
8. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
9. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children
10. GlaxoSmithKline’s Epilepsy Drug given the Green Signal by FD
11. GlaxoSmithKline’s Tykerb is to Be Started Earlier in Breast Cancer, Study Find
Post Your Comments:
(Date:10/13/2008)... - Breakout Docu-Series Follows Three Women ...iends - as They Deliver High-Risk Babies in Th...3 /PRNewswire/ -- Discovery Health is going,back i...season of the hit,docu-series, DELIVER ME. The bre...s of Drs. Yvonne Bohn, Allison Hill and Alane Park...
(Date:10/13/2008)... AtlantaJobs.com and numerous newsp... of www.AtlantaJobs.com . AtlantaJobs.com is the...ocal employers and jobseekers in the metro Atlanta...EB) October 13, 2008 -- AtlantaJobs.com and nume...ial launch of AtlantaJobs.com is the newest onli...
(Date:10/12/2008)...O, Oct. 12 /PRNewswire-USNewswire/ -- Several of C...e dishes in an evening of sampling,and tasting on ...Signature,Chefs Auction. Celebrity Chef and March ...winner of Hell,s Kitchen (season 3) will also be i...ted folate-rich recipe for,women considering becom...
(Date:10/11/2008)...er 2008 An online survey for World Arthritis Day ...ed that access to psychological support and self-m.../rheumatism cope more effectively with their condi...e professionals, people with rheumatic disease and...ght the importance of integrating psychological su...
Breaking Medicine News(10 mins):Health News:Discovery Health is Expecting! Season Two of DELIVER ME is Due on Tuesday, November 11 at 10 PM ET/PT 2Health News:Discovery Health is Expecting! Season Two of DELIVER ME is Due on Tuesday, November 11 at 10 PM ET/PT 3Health News:Atlanta Area Job Board Launches New Local Job Board to Connect Local Employers and Jobseekers 2Health News:Sample Signature Dishes of Chicago's Finest Chefs at the March of Dimes Chicago Signature Chefs Auction on Monday, November 10, 2008 2Health News:Call for new standards of care in arthritis/rheumatism 2
...A new study published in the journal, Molecular Ps... a genetic marker which may make people susceptibl...der and affects around half of young children and ...is harmless, it may sometimes cause injuries to th...
...Former smokers constitute almost half of all newly...ious damage to the lungs that do not disappear as ...ue to recover. It has also been found that smoking...gene that could protect cells from becoming cancer...
...A research project carried out by Juliette van den...at new bone cells can be grown into bone fractures... and bone marrow cells. Researchers inserted a tit...t. They allowed bone marrow cells to grow on this....
...A new study published in the British Medical Journ...ng colorectal cancers at an early stage could be a...chers claimed that nine out of ten bowel and colon...ed and that once the cancer has spread cure rates ...
Other Medicine News:Health News:Bones repair themselves with bone marrow cells 2
(Date:10/10/2008)...s., Oct. 10 /- Inverness Me...rovider of near-patient,diagnostics, monitoring an...Ban Ki-moon, the Secretary-General of the United N... seventeen of the world,s leading,research-based a....,Inverness, together with senior officials from t...
(Date:10/9/2008)...an Campaign to Spread Awareness and Bring Hope to .../PRNewswire-USNewswire/ -- 133 million children,ac...uses such as natural,disaster, civil war, and dise...rving World Orphan Week by calling attention to th...edia News Release, go to:, http://www.prnewswire...
(Date:10/9/2008)...nical Results Expected in November 2008, BOTHELL,...rma, Inc.,(Amex: DDD ) announced today the comple...d of its three pivotal trials to evaluate the safe...nded-release (ER) ibuprofen for,the over-the-count...-line,results from this pivotal trial in November ...
(Date:10/8/2008)...Va., Oct. 8 /PRNewswire-USNewswire/ -- The facts a...e from HIV/AIDS in,sub-Saharan Africa. More than 3...Africa have already died of AIDS. The Foundation f...sure the dying and their families,find compassion ...A,s,innovative partnering initiative links African...
Breaking Medicine Technology:Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 2Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General 3Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 2In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 3In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices 4Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 1Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 2Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 3Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 4Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 5Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 6Senior Citizens Unions Physicians and Nurses Groups Lend Support to Hospitals State House Rally 19082 7Synvista Therapeutics to Present at Acumen BioFin Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5320 1Synvista Therapeutics to Present at Acumen BioFin Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5320 2Synvista Therapeutics to Present at Acumen BioFin Rodman 26 Renshaw 5th Annual Global Healthcare Conference 5320 3APIC Recommendations on Infection Prevention in Long Term Care Facilities 19075 1APIC Recommendations on Infection Prevention in Long Term Care Facilities 19075 2Neuralstem Responds to New StemCells Inc Lawsuit 5315 1Neuralstem Responds to New StemCells Inc Lawsuit 5315 2
...inocycline Showed Substantial,Reduction of Disease...ing Multiple Sclerosis , Combination Treatment Wit... Well Tolerated , KANSAS CITY, Mo, May 4, 2007 - N...ed that a combination of Copaxone,(glatiramer acet...cycline reduced T1 Gadolinium (Gd)-enhancing lesio...
...E)--May 4, 2007 - New data from a,randomized, doub...NE(R) (glatiramer acetate injection) along with th...m (Gd)-enhancing lesions,of the brain by 63 percen...ting multiple sclerosis (RRMS), as measured by,mag...eceiving,COPAXONE(R) alone. Additionally, the nine...
Other Medicine Technology:Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 6Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 7Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 8Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 9Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 10Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 11Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 12Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 2Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 3Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 4Treatment with Copaxone Plus Minocycline Showed Substantial,Reduction of Disease Activity in Patients with Active,Relapsing-Remitting Multiple Sclerosis 5
... package designed to assist in the operations of t...s manufacturer with years of experience in produci...cts is designed to help you run your lab the way y...,Designed specifically for integrated retail and...
The table-mounted knee retractor system provides hands-free exposure for total knee arthroplasty and revisions. The flexible, open-frame design allows for easy movement of the knee during the procedu
...urgery need. No matter the size of the incision or...tor Systems give you the best possible exposure in...mall frame arms, along with the hinged extension a...nd completely scalable access and excellent exposu...
Don't miss the sounds you need to hear! Amplify heart, lung, and other body sounds while reducing distracting ambient noise with the Littmann Model 3000., ,With Ambient Noise Reduction (ANR) tech
Medicine Products: